Single-Use Device Exclusion from Argentinas Refurbished Import Framework

Updated: 2026-11-12 · GRZAN Regulatory Team · Verification date 2026-10-20

1. Key takeaways

Single-use devices may not be imported under the refurbished-import framework of Disposición ANMAT 224/2026. This is the only absolute exclusion in the framework, and there is no exception channel — no waiver, no special authorization, no conditional pathway for particular buyers or particular equipment states. The exclusion is categorical, which makes the screening step at the start of every project straightforward: the attribute is either present or absent.

The remaining 2 constraints are: refurbishment must be carried out by an authorized entity or an equivalent entity; and Class III/IV used or refurbished equipment requires ANMAT prior authorization, while Class I/II equipment follows the 48-hour notification after customs clearance. Refurbished equipment must additionally carry the specific label marking its refurbished status. Read together, the exclusion plus the two constraints form the complete gate sequence a used-equipment project must pass before any shipment is booked.

2. Legal basis

RegulationReference numberPublication dateRelevant provisions
Import rules for used/refurbished medical devicesDisposición ANMAT 224/2026Published February 2, 2026Single-use device exclusion provisions; refurbishing-entity qualification provisions; risk classification provisions; labeling provisions
MERCOSUR technical regulation for medical device registrationGMC/RES 25/21October 13, 2021Part I (used/refurbished equipment outside the scope of application)
Import facilitation for Class I/II productsDisposición ANMAT 4446/2025Published June 24, 2025, effective 30 days after publication48-hour notification provisions

3. Expert insights

Insight 1: The single-use exclusion operates at the level of product attributes, not at the level of procedure. It means that regardless of who the importer is, regardless of the equipment’s condition, and regardless of whether the original manufacturer issues a certificate, single-use devices cannot enter through this channel. The design logic of the exclusion is safety first: the structure and materials of single-use devices are not engineered to support reprocessing in the first place, so no amount of documentation can cure the underlying attribute. That is also why the check belongs at the very front of the workflow, applied to the product record rather than to the shipment paperwork.

Insight 2: The authorized-or-equivalent-entity requirement preserves the quality floor for refurbishment. Although Disposición 224/2026 abolished the CIBU and widened the circle of importers, the refurbishment work itself must still be performed by an authorized or equivalent entity. What has been opened up is who may import; what has been held fixed is who may refurbish. The two openings should not be confused: a clinic that can now import used equipment still cannot refurbish it in its own workshop unless it qualifies as an authorized or equivalent entity.

Insight 3: The compliance judgment should follow a four-step sequence. Step one: determine whether the device is single-use — if yes, the analysis ends there. Step two: determine which of the three import scenarios applies. Step three: determine the risk class to fix the approval intensity. Step four: assemble the three evidence sets (refurbishment certificate, remaining useful life assessment, safety and performance evidence) plus the refurbished label. The order cannot be inverted, because each step can terminate the project or redirect it before the next step’s effort is spent.

4. Practical recommendations

  1. Flag the single-use attribute in the product ledger. Use the attribute as the first screen of every import compliance check, so that any used/refurbished import application passes this gate before any other effort is invested.
  2. Commission refurbishment to an authorized or equivalent entity. Retain the entity’s authorization evidence and the refurbishment records as documentation that can be shown to ANMAT in an inspection.
  3. Schedule the prior authorization for Class III/IV equipment early. The import approval time for high-risk equipment must be counted into delivery commitments; do not quote on a clearance-and-release basis.
  4. Manage refurbished labels as a separate label version. The label marking the refurbished status is mandatory; it must be designed separately and brought into label version control alongside the regular labeling.

5. Verification checklist

  • □ Confirmed the product is not a single-use device
  • □ The specific classification among the three import scenarios determined
  • □ Refurbishment performed by an authorized or equivalent entity, with evidence retained
  • □ Approval pathway confirmed by risk class (48-hour notification / prior authorization)
  • □ The three document sets complete: refurbishment certificate, remaining useful life assessment, safety and performance evidence
  • □ The refurbished-status label designed, applied, and brought under version control

Regulatory information verified as of October 29, 2026.

The four-step sequence also functions as an audit trail for the decisions themselves. When each step is recorded — the single-use determination with its basis, the scenario classification, the risk class, and the evidence set assembled — the file demonstrates to ANMAT that the exclusion was actively considered rather than overlooked. This matters because the absolute exclusion of single-use devices is the kind of provision that inspectors probe first: a company that can show a documented determination closes the question in minutes, while one that cannot invites a deeper look at every other document in the dossier. Embedding the sequence into the product ledger and the import application form turns a one-time legal analysis into a repeatable operating control.

In Argentina, GRZAN operates a wholly-owned subsidiary that can serve as the registration holder and importer for foreign manufacturers, directly handling classification determination, pathway selection, GMP and CFS documentation chains, Spanish-language technical documentation and label localization, HELENA submissions and deficiency responses, as well as BONITA import notifications, ARGOS vigilance system operation, change maintenance, and 5-year renewal planning.

The GRZAN regulatory team consists of professionals with many years of hands-on international registration experience and tracks the dynamics of regulatory authorities across countries on an ongoing basis. All external content follows the drafting standard of conclusions first, traceable bases, and verifiable figures. For an Argentina or MERCOSUR market access plan tailored to a specific product, contact the GRZAN regulatory team at info@grzanglobal.com.

Disclaimer

Prepared by GRZAN from publicly available regulation. It is provided for general information only and does not constitute legal advice. Legislation and official fees are subject to change by the competent authority.

About GRZAN

GRZAN (Global Regulatory Zone Access Navigator) — the global market-access navigator for medical devices and IVDs.

GRZAN is a specialist consultancy for medical device and IVD market access, providing end-to-end regulatory solutions across the product lifecycle and making international market entry simpler and faster.

Key figures. More than 25 wholly owned subsidiaries worldwide covering 50+ countries and regions; chosen by 100+ listed and leading Chinese device manufacturers, with 4,000+ successful cases; 12+ years in the sector and 200+ regulatory training sessions and seminars delivered.

What we do. Global market access: multi-country registration programmes, technical documentation, regulatory advice. Clinical evidence: clinical evaluation reports (CER), usability studies, overseas clinical investigations. Quality systems: ISO 13485, MDSAP, FDA QMSR and BGMP implementation and audit readiness. Authorised representative and licence-holder services across Southeast Asia, Latin America, the Middle East, Africa, Europe and North America.

Why GRZAN. A real operating entity, with the certificate held by the manufacturer: our direct overseas subsidiaries act as the compliant local holder, so the regulatory relationship stays clear and you keep control rather than being tied to a distributor. Direct access to the team: no time-zone gap, no language barrier, no cultural gap. Review points anticipated: we know what FDA 510(k), EU MDR, Southeast Asian, Latin American and Middle Eastern reviewers look for, which shortens timelines and reduces deficiency letters. Pathway planning: pre-decision analysis and risk assessment before you commit.

Every engagement rests on three commitments: efficiency through pre-submission review, certainty through a clear pathway, and stability through a licence-holder that stays in place.

Take your devices global with GRZAN

We work with manufacturers worldwide to open new markets with a clear regulatory pathway.

Contact us
WhatsApp
QR Code
WhatsApp QR Code
Scan to chat on WhatsApp
Phone
Call
Office Mon-Fri 9:00-18:00
0755-88659477
Mobile 24/7 Service
+86 15816864648
Email
Mail